Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache

NCT00432549 is registered in ClinicalTrials.gov with The New England Center for Headache, P.C. as lead sponsor.

NCT NCT00432549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache
Lead sponsor
The New England Center for Headache, P.C.
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2007
Completion date
February 28, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesic rebound headache